Longitudinal assessment of circulating insulin-like peptide 3 levels in healthy peripubertal girls  Casper P. Hagen, Ph.D., Mikkel G. Mieritz, M.D., John.

Slides:



Advertisements
Similar presentations
Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States  David B. Seifer, M.D., Valerie.
Advertisements

Longitudinal assessment of circulating insulin-like peptide 3 levels in healthy peripubertal girls  Casper P. Hagen, Ph.D., Mikkel G. Mieritz, M.D., John.
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,
Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M
Study of nucleation status in the second cell cycle of human embryo and its impact on implantation rate  Jesus Aguilar, Ph.D., Irene Rubio, Ph.D., Elkin.
Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice  Laura Detti, M.D., Rebecca A. Uhlmann,
Variation in circulating antimüllerian hormone precursor during the periovulatory and acute postovulatory phases of the human ovarian cycle  Michael W.
Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation  W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,
Jong Yeob Choi, Ph. D. , Min Wha Jo, M. S. , Eun Young Lee, M. S
Developmental programming: prenatal testosterone excess disrupts anti-Müllerian hormone expression in preantral and antral follicles  Almudena Veiga-Lopez,
Relationships between the luteinizing hormone surge and other characteristics of the menstrual cycle in normally ovulating women  Ana Direito, M.D., Sébastien.
Gonadotropin-releasing hormone agonist trigger in oocyte donors co-treated with a gonadotropin-releasing hormone antagonist: a dose-finding study  Thi.
Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti- Müllerian hormone levels  Hye Jin Chang, M.D., Ph.D., Sang Hoon Han,
Reporting in vitro fertilization cycles to the Society for Assisted Reproductive Technology database: where have all the cycles gone?  David Kulak, M.D.,
Ovarian morphology and function during growth hormone therapy of short girls born small for gestational age  Jeanette Tinggaard, M.D., Rikke Beck Jensen,
Low concentration of circulating antimüllerian hormone is not predictive of reduced fecundability in young healthy women: a prospective cohort study 
Ramifications of adolescent menstrual cycles ≥42 days in young adults
Antimüllerian hormone levels decrease in women using combined contraception independently of administration route  Sanna Kallio, M.D., Johanna Puurunen,
Rene Ecochard, M. D. , Ph. D. , Thomas Bouchard, M. D. , Rene Leiva, M
Ovarian pregnancy after in vitro fertilization
Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause  Linlin Cui, M.D., Ph.D., Yingying.
Neohormones as biomarkers of reproductive health
Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome  Pascal Pigny, Ph.D., Elisse Gorisse,
Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women  Carlos Iglesias, M.D., Manish Banker, M.D.,
Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women  Ellen W. Freeman, Ph.D.,
Satin S. Patel, M.D., Kelley S. Carrick, M.D., Bruce R. Carr, M.D. 
Anti-Müllerian hormone: correlation of early follicular, ovulatory and midluteal levels with ovarian response and cycle outcome in intracytoplasmic sperm.
A comparison of blood spot vs
Ellen W. Freeman, Ph. D. , Clarisa R. Gracia, M. D. , Mary D
Mikkel Rosendahl, M. D. , Claus Yding Andersen, D. M. Sc
A Markov model of the cost-effectiveness of human-derived follicle-stimulating hormone (FSH) versus recombinant FSH using comparative clinical trial data 
Uterine volume and endometrial thickness in healthy girls evaluated by ultrasound (3- dimensional) and magnetic resonance imaging  Casper P. Hagen, M.D.,
Oocyte cryopreservation
Differences in gene expression of granulosa cells from women undergoing controlled ovarian hyperstimulation with either recombinant follicle-stimulating.
Deleterious effect of tobacco on IVF outcome and ovarian reserve as reflected by serum anti mullerian hormone (AMH)  P. Barriere, T. Freour, D. Masson,
Pregnancy-associated plasma protein A in human ovarian follicles and its association with intrafollicular hormone levels  Jane Alrø Bøtkjær, M.Sc., Janni.
Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone.
Robert F. Casper, M.D.  Fertility and Sterility 
Anastrozole vs. clomiphene citrate in infertile women with ovulatory dysfunction: a phase II, randomized, dose-finding study  Donald Tredway, M.D., Ph.D.,
Race/ethnic disparities in reproductive age: an examination of ovarian reserve estimates across four race/ethnic groups of healthy, regularly cycling.
Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study  Frederic Mitri,
Monocyte chemotactic protein-1 (MCP-1), its receptor, and macrophages in the perifollicular stroma during the human ovulatory process  Pernilla Dahm-Kähler,
Circulating antimüllerian hormone levels in boys decline during early puberty and correlate with inhibin B  Matti Hero, M.D., Ph.D., Johanna Tommiska,
Duphaston and human menopausal gonadotropin protocol in normally ovulatory women undergoing controlled ovarian hyperstimulation during in vitro fertilization/intracytoplasmic.
Tomer Singer, M. D. , David H. Barad, M. D. , M. S
Robotic-assisted laparoscopic ovarian tissue transplantation
Interaction of apolipoprotein E gene polymorphisms on miscarriage risk in black and white American women  Silvia Gamundi-Segura, M.Sc., Elena Torres-Perez,
Serum insulin-like factor 3 is highly correlated with intratesticular testosterone in normal men with acute, experimental gonadotropin deficiency stimulated.
Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D. 
Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception  Lauren N.C. Johnson,
Assessment of luteinizing hormone level in the gonadotropin-releasing hormone antagonist protocol  Georg Griesinger, M.D., Anja Dawson, M.D., Askan Schultze-Mosgau,
MaryFran Sowers, Ph. D. , Daniel McConnell, Ph. D
Simple tools for assessment of ovarian reserve (OR): individual ovarian dimensions are reliable predictors of OR  Stacea Bowen, M.D., John Norian, M.D.,
Antecubital vein venous sampling does not distort circulating levels of peptide and sex steroid hormones  Michael P. Diamond, M.D., Michael Kruger, M.S.,
FSHB-211 and FSHR 2039 are associated with serum levels of follicle-stimulating hormone and antimüllerian hormone in healthy girls: a longitudinal cohort.
Human granulosa-lutein cell in vitro production of progesterone, inhibin A, inhibin B, and activin A are dependent on follicular size and not the presence.
Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.
Richard M. Sharpe, Ph.D., Niels E. Skakkebaek, M.D. 
The serum follicle-stimulating hormone-to-luteinizing hormone ratio at the start of stimulation with gonadotropins after pituitary down-regulation is.
Fertility and Sterility: an evaluation
Serum levels of antimüllerian hormone in early maturing girls before, during, and after suppression with GnRH agonist  Casper P. Hagen, M.D., Kaspar Sørensen,
Ethnicity or environment: effects of migration on ovarian reserve among Bangladeshi women in the United Kingdom  Khurshida Begum, M.B.B.S., Ph.D., Shanthi.
A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child  Xin Chen, M.D., M.Sc., Shi-ling Chen,
Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients  Scott M. Nelson, Ph.D., Martina C. Messow,
Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function  David H. Barad, M.D., M.S., Andrea Weghofer,
Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D
Bárbara Oriol, M. D. , Ana Barrio, M. D. , Alberto Pacheco, Ph. D
The ReSTAGE Collaboration: defining optimal bleeding criteria for onset of early menopausal transition  Siobán D. Harlow, Ph.D., Ellen S. Mitchell, Ph.D.,
Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization  Rongrong Tan, M.M.Sc., Danhua Pu,
Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment  Daniel Bodri, M.D., M.Sc.,
Presentation transcript:

Longitudinal assessment of circulating insulin-like peptide 3 levels in healthy peripubertal girls  Casper P. Hagen, Ph.D., Mikkel G. Mieritz, M.D., John E. Nielsen, M.Sc., Ravinder Anand-Ivell, Ph.D., Richard Ivell, Ph.D., Anders Juul, D.M.Sc.  Fertility and Sterility  Volume 103, Issue 3, Pages 780-786.e1 (March 2015) DOI: 10.1016/j.fertnstert.2014.11.014 Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Serum levels of INSL3 in 10 healthy peripubertal girls (A–J) according to age (A) and time to pubertal onset (B). The detection limit of INSL3 (0.01 ng/mL) is marked with a black, dashed line. When all samples were included in a cross-sectional model, serum levels of INSL3 were lower in samples from prepubertal girls (B1) vs. girls in late puberty (B4+B5): 0.01 (<0.01–0.13) vs. 0.05 (0.01–0.25) ng/mL, P=.031 (C). Median, 10th and 90th percentile (black line and grey box). The postpubertal increase of INSL3 was confirmed by a component variant model taking longitudinal values into account (D). Geometric mean (fat black line), ±1.96 SD (thin black lines) corresponding to the 95% confidence interval. Insulin-like peptide 3 levels at first examination after pubertal onset vs. >2 years after pubertal onset: 0.03 (0.02–0.06) vs. 0.15 (0.07–0.33) ng/mL, P=.004. Fertility and Sterility 2015 103, 780-786.e1DOI: (10.1016/j.fertnstert.2014.11.014) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Two representative examples (girl A: left; and girl B: right) of individual variation of INSL3 levels, LH, and theca cell products (T and A) (upper panel) as well as FSH and granulosa cell products (E2, inhibin B, and AMH) (lower panel) according to pubertal onset (marked with vertical grey line). The detection limit of INSL3 (0.01 ng/mL) is marked with a black, dashed line. Fluctuations of INSL3 were not always parallel with gonadotropins or ovarian hormones. Insulin-like peptide 3 reflected products from large follicles (T, A, E2, inhibin B) better than products from small follicles (AMH). Fertility and Sterility 2015 103, 780-786.e1DOI: (10.1016/j.fertnstert.2014.11.014) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 3 Positive immunohistochemical intracytoplasmatic staining of INSL3 (A) and CYP11A1 (B) in theca cells of a large follicle (>4 mm). Control with omission of INSL3 antibody (D). The majority of granulosa cells of preantral follicles (<1 mm) did not stain for INSL3 (C). A, B, and D are serial sections from a 15-year-old girl. C is from a 14-year-old girl. Fertility and Sterility 2015 103, 780-786.e1DOI: (10.1016/j.fertnstert.2014.11.014) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 Insulin-like peptide 3 correlated with T (P=.002) (A), A (P=.003) (B), E2 (P=.004) (C), inhibin B (P=.006) (D), LH (P=.003), and FSH (P=.029) (red) (E) but not with AMH (P=.549) (F). All samples (n = 84) from the 10 girls were included. Fertility and Sterility 2015 103, 780-786.e1DOI: (10.1016/j.fertnstert.2014.11.014) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions